112 related articles for article (PubMed ID: 33109555)
21. The polarization of immune cells in the tumour environment by TGFbeta.
Flavell RA; Sanjabi S; Wrzesinski SH; Licona-Limón P
Nat Rev Immunol; 2010 Aug; 10(8):554-67. PubMed ID: 20616810
[TBL] [Abstract][Full Text] [Related]
22. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
23. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.
Verma C; Kaewkangsadan V; Eremin JM; Cowley GP; Ilyas M; El-Sheemy MA; Eremin O
J Transl Med; 2015 Jun; 13():180. PubMed ID: 26040463
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta/transforming growth factor-betaRII signaling may regulate CD4+CD25+ T-regulatory cell homeostasis and suppressor function in feline AIDS lentivirus infection.
Petty CS; Tompkins MB; Tompkins WA
J Acquir Immune Defic Syndr; 2008 Feb; 47(2):148-60. PubMed ID: 18091047
[TBL] [Abstract][Full Text] [Related]
25. IL-23 promotes tumour incidence and growth.
Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract][Full Text] [Related]
28. Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.
Holen I; Nutter F; Wilkinson JM; Evans CA; Avgoustou P; Ottewell PD
Clin Exp Metastasis; 2015 Oct; 32(7):689-702. PubMed ID: 26231669
[TBL] [Abstract][Full Text] [Related]
29. Tissue-engineered nanoclay-based 3D in vitro breast cancer model for studying breast cancer metastasis to bone.
Kar S; Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2019 Feb; 13(2):119-130. PubMed ID: 30466156
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells.
Peiris-Pagès M; Sotgia F; Lisanti MP
Oncotarget; 2015 May; 6(13):10728-45. PubMed ID: 25915429
[TBL] [Abstract][Full Text] [Related]
31. 3D multicellular models to study the regulation and roles of acid-base transporters in breast cancer.
Czaplinska D; Elingaard-Larsen LO; Rolver MG; Severin M; Pedersen SF
Biochem Soc Trans; 2019 Dec; 47(6):1689-1700. PubMed ID: 31803922
[TBL] [Abstract][Full Text] [Related]
32. The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis.
Lim JA; Oh CS; Yoon TG; Lee JY; Lee SH; Yoo YB; Yang JH; Kim SH
BMC Cancer; 2018 Feb; 18(1):159. PubMed ID: 29415668
[TBL] [Abstract][Full Text] [Related]
33. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
Zhou H; Chen L; You Y; Zou L; Zou P
Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
[TBL] [Abstract][Full Text] [Related]
34. Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.
Schmidt A; Zhang XM; Joshi RN; Iqbal S; Wahlund C; Gabrielsson S; Harris RA; Tegnér J
Immunol Cell Biol; 2016 Sep; 94(8):747-62. PubMed ID: 27075967
[TBL] [Abstract][Full Text] [Related]
35. Cytokines facilitate chemotactic motility of breast carcinoma cells.
Arihiro K; Oda H; Kaneko M; Inai K
Breast Cancer; 2000; 7(3):221-30. PubMed ID: 11029802
[TBL] [Abstract][Full Text] [Related]
36. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
[TBL] [Abstract][Full Text] [Related]
37. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
[TBL] [Abstract][Full Text] [Related]
38. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
39. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
[TBL] [Abstract][Full Text] [Related]
40. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
